Background Fast Fact #66 discussed the physiology and methods of delivering radiation therapy (XRT). This Fast Fact reviews the common indications for and outcomes of palliative XRT.
Decision Making The most important decision when considering palliative XRT is to assess the balance between anticipated functional/symptomatic benefit versus time spent receiving therapy and acute toxicities. It is vital to review 1) the estimated prognosis, 2) current and anticipated best functional status outcome, 3) expected toxicities, and 4) treatment burden—time spent coming to XRT site, time off work for family, and cost.
Bone Metastases External beam therapy achieves pain relief in over 75% of patients with healing and reossification occurring in 65-85% of lytic lesions in non-fractured bone. Pain relief may begin within the first few treatments and peaks by 4 weeks following XRT completion. A standard radiation prescription in the US is 300 cGy x 10 fractions. However, data exist to support a single large fraction (800 cGy x 1) for extremity lesions, especially in patients with expected survival < 3 months. Surgical fixation prior to XRT is indicated for large lesions, when >50% of the cortex is replaced by tumor, or when fracture has occurred in a weight-bearing bone.
Radionuclide therapy with Strontium 89 or Samarium 153 is indicated for multiple sites of painful bone metastases (typically breast or prostate cancer). Peak analgesic effect occurs 3-6 weeks following treatment. Side effects are hematological with decreased blood counts in 10-30% of patients. Worsening of pain (a ‘pain flare’) may occur following administration and prior to pain relief. Radionuclide therapy can be combined with external beam radiation and can be given more than once.
Epidural Metastases and Spinal Cord Compression External beam radiation is the primary definitive treatment for epidural metastases with or without spinal cord compression, in conjunction with a short-course of steroids. The standard US prescription is 300 cGy x 10 fractions, although shorter courses can be used if needed (e.g. 400 cGy x 5). Results of treatment are directly related to the neurological status at the time treatment starts. Ambulatory patients at the start of treatment generally remain ambulatory, while non-ambulatory patients are unlikely to have return of weight-bearing function. Indications for surgery include no tissue diagnosis, spinal instability, bone fragments causing cord damage and progression during/after XRT.
Brain Metastases Whole-brain external beam radiation or – for small lesions – stereotactic radiosurgery (e.g. ‘Gamma Knife’), can relieve symptoms and prolong survival. The standard US prescription is 300 cGy x 10 fractions; although shorter courses can be used (e.g. 400 cGy x 5). Surgery is indicated for good prognosis patients with a single accessible lesion or for refractory neurological symptoms (e.g. seizures).
Other Indications The following are all appropriate for consideration of palliative radiation:
- Obstruction: vascular (superior vena cava syndrome), esophagus, airway, rectum, biliary tract
- Pain: adrenal metastases causingflank pain, tumors causing nerve impingement
- Bleeding: stomach, esophagus, head/neck cancer, bladder, cervix
- Ciezki JP. Palliative Radiotherapy. Seminars in Oncology. 2000; 27(1):90-3.
- Kirkbride P. The role of radiation therapy in palliative care. J Palliat Care. 1995; 11(1):19-
- Perez C, Brady L, Chao KSC, eds. Radiation Oncology: Management Decisions. 3 rd Ed.
Philadelphia, PA: Lippincott-Raven; 1999.
- Tisdale BA. When to consider radiation therapy for your patient. Am Fam Phys. 1999;
- Labow DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord
compression: an evidence-based guideline. J Clin Oncol. 1998; 16(4):1613-24.
- Kirkbride P, Bezjak. Palliative Radiation Therapy. In: Berger A, Portenoy R, Weissman
DE, eds. Principles and Practice of Palliative Care and Supportive Oncology. New York,
NY: Lippincott Wilkins & William; 2002.
Version History: This Fast Fact was originally edited by David E Weissman MD. 2 nd Edition published September 2006. Current version re-copy-edited April 2009.
Fast Facts and Concepts are edited by Sean Marks MD (Medical College of Wisconsin) and associate editor Drew A Rosielle MD (University of Minnesota Medical School), with the generous support of a volunteer peer-review editorial board, and are made available online by the Palliative Care Network of Wisconsin (PCNOW); the authors of each individual Fast Fact are solely responsible for that Fast Fact’s content. The full set of Fast Facts are available at Palliative Care Network of Wisconsin with contact information, and how to reference Fast Facts.
Copyright: All Fast Facts and Concepts are published under a Creative Commons Attribution-NonCommercial 4.0 International Copyright (http://creativecommons.org/licenses/by-nc/4.0/). Fast Facts can only be copied and distributed for non-commercial, educational purposes. If you adapt or distribute a Fast Fact, let us know!
Disclaimer: Fast Facts and Concepts provide educational information for health care professionals. This information is not medical advice. Fast Facts are not continually updated, and new safety information may emerge after a Fast Fact is published. Health care providers should always exercise their own independent clinical judgment and consult other relevant and up-to-date experts and resources. Some Fast Facts cite the use of a product in a dosage, for an indication, or in a manner other than that recommended in the product labeling. Accordingly, the official prescribing information should be consulted before any such product is used.